NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cordance Medical

Cordance Medical

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://cordancemedical.com/

Last Round

Seed

Nov 24, 2025

Total Funding Raised

$20.85M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cordance Medical is a medical device company developing a non-invasive ultrasound system, the NeuroAccess™ platform, to reversibly open the blood-brain barrier, enabling precision medicine for brain diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

blood-brain barrier openingfocused ultrasoundliquid biopsybrain drug deliveryBBB openingFUSneurotechbrain liquid biopsyneuro-oncologymedical devicemicrobubblestherapeutic deliverybiomarker analysisultrasound contrast agentsbrain tumorsFDA Breakthrough Devicecell-free DNAcfDNA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cordance Medical Comps

Public and private peers based on sector, stage, and business model.

Cordance Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cordance Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 24, 2025
GrantSep 19, 2024
Series AFeb 8, 2023
SeedAug 1, 2022
GrantJul 16, 2021
Grant
May 15, 2020

Key People

Founding team and executive leadership

Bhaskar Ramamurthy

Founder CTO

Founding Team

Cordance Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 24, 2025

    $8M raised in Seed round.

  • Sep 19, 2024

    $399K grant from National Cancer Institute and NIH RADx.

Cordance Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cordance Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cordance Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMountain View, California
Employee Range13
Year Founded2018
Last FundingNov 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.